Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China flag China · Delayed Price · Currency is CNY
62.21
+1.11 (1.82%)
Mar 20, 2026, 11:22 AM CST

SHA:688621 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,2181,077930.98676.39492.86
Other Revenue
-1.611.140.210.79
1,2181,078932.12676.61493.65
Revenue Growth (YoY)
12.92%15.70%37.76%37.06%42.12%
Cost of Revenue
-537.33403.77301.15229.97
Gross Profit
1,218541.14528.35375.46263.68
Selling, General & Admin
-150.44153.24110.8185.63
Research & Development
-171.94123.6889.6947.58
Other Operating Expenses
1,0140.760.20.160.04
Operating Expenses
1,014364.82334.89219.32143.72
Operating Income
204.2176.32193.46156.14119.97
Interest Expense
--16.11-12.18-9.7-3.56
Interest & Investment Income
-5.678.538.782.52
Other Non Operating Income (Expenses)
-3.12-2.66-2.47-0.96-0.72
EBT Excluding Unusual Items
201.08163.22187.35154.25118.21
Gain (Loss) on Sale of Investments
--1.82---
Gain (Loss) on Sale of Assets
--0.31-0.71-0.25-0.51
Other Unusual Items
-14.96.7615.144.4
Pretax Income
201.08175.99193.4169.14122.1
Income Tax Expense
56.9710.510.4313.31
Earnings From Continuing Operations
196.08169.01182.9158.7108.79
Minority Interest in Earnings
-8.41.86-2.23-3.13
Net Income
196.08177.41184.76156.47105.66
Net Income to Common
196.08177.41184.76156.47105.66
Net Income Growth
10.53%-3.98%18.08%48.09%45.81%
Shares Outstanding (Basic)
11011211211298
Shares Outstanding (Diluted)
11011211211298
Shares Change (YoY)
-2.44%0.28%0.19%14.09%16.84%
EPS (Basic)
1.791.581.651.401.08
EPS (Diluted)
1.791.581.651.401.08
EPS Growth
13.29%-4.24%17.86%29.80%24.80%
Free Cash Flow
-1.5419.90.093.29
Free Cash Flow Per Share
-0.010.180.000.03
Dividend Per Share
-0.1630.1650.4290.189
Dividend Growth
--1.21%-61.50%126.41%-
Gross Margin
100.00%50.18%56.68%55.49%53.41%
Operating Margin
16.77%16.35%20.76%23.08%24.30%
Profit Margin
16.10%16.45%19.82%23.13%21.40%
Free Cash Flow Margin
-0.14%2.14%0.01%0.67%
EBITDA
229.58201.69215.47173.19131.47
EBITDA Margin
18.85%18.70%23.12%25.60%26.63%
D&A For EBITDA
25.3825.3822.0117.0511.5
EBIT
204.2176.32193.46156.14119.97
EBIT Margin
16.77%16.35%20.76%23.08%24.30%
Effective Tax Rate
2.48%3.96%5.43%6.17%10.90%
Revenue as Reported
-1,078932.12676.61493.65
Advertising Expenses
-0.581.691.171.13
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.